{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:52Z","timestamp":1792785052734,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the General Project of the Zhejiang Medicine Health Science and Technology Plan"},{"name":"Zhejiang Province science and technology plan project"},{"name":"the National Natural Science Foundation of China","id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Identifying serum biomarkers that accurately reflect the progression of coronary artery disease (CAD) remains a major challenge. Integrative proteomic and metabolomic profiling can provide novel insights into disease pathogenesis and improve clinical prediction. We conducted a four-phase study. In the discovery phase, serum from 40 patients (controls, stable CAD, and acute coronary syndrome (ACS)) was analyzed using data-independent acquisition (DIA) proteomics and liquid chromatography-tandem mass spectrometry (LC\u2013MS)\/gas chromatography\u2013mass spectrometry (GC\u2013MS) metabolomics to identify differentially expressed proteins (DEPs) and metabolites. In the verification phase, selected DEPs were validated by parallel reaction monitoring (PRM) in an independent 40-patient cohort. In the derivation phase, six validated proteins were measured by ELISA in 207 angina patients to assess their association with coronary obstruction (\u2265\u200950% stenosis). In the validation phase, a support vector machine (SVM) model incorporating clinical risk factors and these biomarkers was developed in the derivation cohort and tested in an independent 97-patient cohort. Model performance was evaluated using receiver operating characteristic (ROC) curves and decision curve analysis. Coronary obstruction is defined as \u2265\u200950% luminal diameter stenosis in at least one major coronary artery on angiography. Proteomic analysis identified 97 DEPs, and metabolomic profiling revealed 322 DEMs (including 289 from LC\u2013MS and 33 from GC\u2013MS analyses). Seven proteins showed consistent changes in both DIA and PRM validation. Among these, thrombospondin-1 (TSP-1) was significantly upregulated in stable CAD compared with controls, while serum amyloid A1 (SAA1) was markedly elevated in ACS compared with stable CAD. In an independent angina cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009207), serum levels of TSP-1 and SAA1 were significantly higher in patients with coronary obstruction. Multivariate logistic regression adjusted for conventional cardiovascular risk factors (including age, sex, homocysteine, and other clinical variables) demonstrated that TSP-1 remained independently associated with coronary artery occlusion (OR\u2009=\u20091.424, 95% CI 1.057\u20131.918,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.020). A support vector machine (SVM) model incorporating conventional clinical risk factors was constructed, and the addition of TSP-1 and SAA1 significantly improved diagnostic performance for CAD severity (AUC\u2009=\u20090.919 in derivation, 0.992 in validation). In conclusion, our dual-omics approach identified novel biomarkers and pathways in CAD progression. The SVM-based prediction model offers a promising non-invasive tool for early CAD detection, potentially reducing unnecessary invasive procedures.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-60840-z","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:28:13Z","timestamp":1783092493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum integrative omics reveals predictive signatures for coronary artery disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Kai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsha","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6754-1432","authenticated-orcid":false,"given":"Xiaogang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"60840_CR1","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBDC Collaborators","year":"2024","unstructured":"Collaborators, G. B. D. C. o. D. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2100\u20132132. https:\/\/doi.org\/10.1016\/S0140-6736(24)00367-2 (2024).","journal-title":"Lancet"},{"key":"60840_CR2","doi-asserted-by":"publisher","first-page":"Itc145","DOI":"10.7326\/ANNALS-25-03512","volume":"178","author":"MM Kittleson","year":"2025","unstructured":"Kittleson, M. M. Chronic coronary artery disease. Ann. Intern. Med. 178, Itc145\u2013itc160 (2025).","journal-title":"Ann. Intern. Med."},{"key":"60840_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ejcts\/ezy289","volume":"55","author":"M Sousa-Uva","year":"2019","unstructured":"Sousa-Uva, M. et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur. J. Cardiothorac. Surg. 55, 4\u201390. https:\/\/doi.org\/10.1093\/ejcts\/ezy289 (2019).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"60840_CR4","doi-asserted-by":"publisher","first-page":"e037264","DOI":"10.1161\/JAHA.124.037264","volume":"14","author":"K Welen Schef","year":"2025","unstructured":"Welen Schef, K., Tornvall, P., Lindahl, B., Nordenskjold, A. M. & Jernberg, T. Angina pectoris prevalence and sick leave burden 1 year after myocardial infarction with nonobstructive coronary arteries. J. Am. Heart Assoc. 14, e037264. https:\/\/doi.org\/10.1161\/JAHA.124.037264 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"60840_CR5","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001038","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton, J. S. et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145, e18\u2013e114. https:\/\/doi.org\/10.1161\/CIR.0000000000001038 (2022).","journal-title":"Circulation"},{"key":"60840_CR6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.7326\/L16-0480","volume":"165","author":"JP Greenwood","year":"2016","unstructured":"Greenwood, J. P., Herzog, B. A., Brown, J. M., Everett, C. C. & Plein, S. Cardiovascular magnetic resonance and single-photon emission computed tomography in suspected coronary heart disease. Ann. Intern. Med. 165, 830\u2013831. https:\/\/doi.org\/10.7326\/L16-0480 (2016).","journal-title":"Ann. Intern. Med."},{"key":"60840_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12916-023-03197-8","volume":"21","author":"F Yang","year":"2023","unstructured":"Yang, F. et al. Proteomic insights into the associations between obesity, lifestyle factors, and coronary artery disease. BMC Med. 21, 485. https:\/\/doi.org\/10.1186\/s12916-023-03197-8 (2023).","journal-title":"BMC Med."},{"key":"60840_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/atvbaha.124.322346","volume":"45","author":"V Nageswaran","year":"2025","unstructured":"Nageswaran, V. et al. Gut microbial metabolite imidazole propionate impairs endothelial cell function and promotes the development of atherosclerosis. #N\/A 45, 823\u2013839. https:\/\/doi.org\/10.1161\/atvbaha.124.322346 (2025).","journal-title":"#N\/A"},{"key":"60840_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jtcvs.2020.01.079","volume":"162","author":"XY Li","year":"2021","unstructured":"Li, X. Y. et al. Preoperative plasma biomarkers associated with atrial fibrillation after coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 162, 851\u2013863. (2021). https:\/\/doi.org\/10.1016\/j.jtcvs.2020.01.079","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"60840_CR10","doi-asserted-by":"publisher","first-page":"101367","DOI":"10.1016\/j.molmet.2021.101367","volume":"54","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. Serum integrative omics reveals the landscape of human diabetic kidney disease. Mol. Metab. 54, 101367. https:\/\/doi.org\/10.1016\/j.molmet.2021.101367 (2021).","journal-title":"Mol. Metab."},{"key":"60840_CR11","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-025-00818-0","volume":"5","author":"YH Gan","year":"2025","unstructured":"Gan, Y. H. et al. Large-scale proteomic analyses of incident Parkinson\u2019s disease reveal new pathophysiological insights and potential biomarkers. Nat. Aging. 5, 642\u2013657. https:\/\/doi.org\/10.1038\/s43587-025-00818-0 (2025).","journal-title":"Nat. Aging"},{"key":"60840_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13073-024-01356-x","volume":"16","author":"S Si","year":"2024","unstructured":"Si, S., Liu, H., Xu, L. & Zhan, S. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. Genome Med. 16, 84. https:\/\/doi.org\/10.1186\/s13073-024-01356-x (2024).","journal-title":"Genome Med."},{"key":"60840_CR13","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"M Task Force","year":"2013","unstructured":"Task Force, M. et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 34, 2949\u20133003. https:\/\/doi.org\/10.1093\/eurheartj\/eht296 (2013).","journal-title":"Eur. Heart J."},{"key":"60840_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 39, 119\u2013177. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393 (2018).","journal-title":"Eur. Heart J."},{"key":"60840_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi, M. et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur. Heart J. 37, 267\u2013315 https:\/\/doi.org\/10.1093\/eurheartj\/ehv320 (2016).","journal-title":"Eur. Heart J."},{"key":"60840_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/hrt.81.6.621","volume":"81","author":"J Ge","year":"1999","unstructured":"Ge, J. et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart 81, 621\u2013627. https:\/\/doi.org\/10.1136\/hrt.81.6.621 (1999).","journal-title":"Heart"},{"key":"60840_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1056\/NEJM200001133420207","volume":"342","author":"Y Yeghiazarians","year":"2000","unstructured":"Yeghiazarians, Y., Braunstein, J. B., Askari, A. & Stone, P. H. Unstable angina pectoris. N Engl. J. Med. 342, 101\u2013114. https:\/\/doi.org\/10.1056\/NEJM200001133420207 (2000).","journal-title":"N Engl. J. Med."},{"key":"60840_CR18","doi-asserted-by":"publisher","first-page":"l1945","DOI":"10.1136\/bmj.l1945","volume":"365","author":"R Haase","year":"1945","unstructured":"Haase, R. et al. Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: Meta-analysis of individual patient data. BMJ 365, l1945. https:\/\/doi.org\/10.1136\/bmj.l1945 (2019).","journal-title":"BMJ"},{"key":"60840_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jcin.2010.11.017","volume":"4","author":"N Kuriyama","year":"2011","unstructured":"Kuriyama, N., Kobayashi, Y., Yamaguchi, M. & Shibata, Y. Usefulness of rotational atherectomy in preventing polymer damage of everolimus-eluting stent in calcified coronary artery. JACC Cardiovasc. Interv. 4, 588\u2013589 (2011).","journal-title":"JACC Cardiovasc. Interv"},{"key":"60840_CR20","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.jacc.2017.02.001","volume":"69","author":"M Patel","year":"2017","unstructured":"Patel, M. et al. (ed, R.) ACC\/AATS\/AHA\/ASE\/ASNC\/SCAI\/SCCT\/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 69 2212\u20132241 https:\/\/doi.org\/10.1016\/j.jacc.2017.02.001 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"60840_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann, F. J. et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 40, 87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394 (2019).","journal-title":"Eur. Heart J."},{"key":"60840_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"60840_CR23","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013d677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"60840_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1021\/acs.jproteome.7b00651","volume":"17","author":"ESH Cheow","year":"2018","unstructured":"Cheow, E. S. H. et al. Myocardial injury is distinguished from stable angina by a set of candidate plasma biomarkers identified using iTRAQ\/MRM-based approach. J. Proteome Res. 17, 499\u2013515. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00651 (2018).","journal-title":"J. Proteome Res."},{"key":"60840_CR25","doi-asserted-by":"publisher","first-page":"758035","DOI":"10.3389\/fcvm.2021.758035","volume":"8","author":"H Meng","year":"2021","unstructured":"Meng, H. et al. Investigation of specific proteins related to different types of coronary atherosclerosis. Front. Cardiovasc. Med. 8, 758035. https:\/\/doi.org\/10.3389\/fcvm.2021.758035 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"60840_CR26","doi-asserted-by":"publisher","first-page":"692893","DOI":"10.3389\/fendo.2021.692893","volume":"12","author":"Z Jing","year":"2021","unstructured":"Jing, Z. et al. Association of coronary artery disease and metabolic syndrome: Usefulness of serum metabolomics approach. Front. Endocrinol. (Lausanne). 12, 692893. https:\/\/doi.org\/10.3389\/fendo.2021.692893 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"60840_CR27","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.031139","volume":"137","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases. Circulation 137, 1374\u20131390. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.031139 (2018).","journal-title":"Circulation"},{"key":"60840_CR28","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1093\/eurheartj\/ehz235","volume":"40","author":"I Tzoulaki","year":"2019","unstructured":"Tzoulaki, I. et al. Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease. Eur. Heart J. 40, 2883\u20132896. https:\/\/doi.org\/10.1093\/eurheartj\/ehz235 (2019).","journal-title":"Eur. Heart J."},{"key":"60840_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-024-00286-z","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. Stromal thrombospondin 1 suppresses angiogenesis in oral submucous fibrosis. Int. J. Oral Sci. https:\/\/doi.org\/10.1038\/s41368-024-00286-z (2024).","journal-title":"Int. J. Oral Sci."},{"key":"60840_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-024-03318-x","volume":"22","author":"HM Hassan","year":"2024","unstructured":"Hassan, H. M. et al. Thrombospondin 1 enhances systemic inflammation and disease severity in acute-on-chronic liver failure. BMC Med. 22, 95. https:\/\/doi.org\/10.1186\/s12916-024-03318-x (2024).","journal-title":"BMC Med."},{"key":"60840_CR31","doi-asserted-by":"publisher","first-page":"149369","DOI":"10.1016\/j.bbrc.2023.149369","volume":"693","author":"M Imamori","year":"2024","unstructured":"Imamori, M. et al. Thrombospondin-1 promotes liver fibrosis by enhancing TGF-\u03b2 action in hepatic stellate cells. Biochem. Biophys. Res. Commun. 693, 149369. https:\/\/doi.org\/10.1016\/j.bbrc.2023.149369 (2024).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"60840_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.6515\/acs20140630d","volume":"31","author":"CL Huang","year":"2015","unstructured":"Huang, C. L. et al. Association of plasma thrombospondin-1 level with cardiovascular disease and mortality in hemodialysis patients. Acta Cardiol. Sin. 31, 113\u2013119. https:\/\/doi.org\/10.6515\/acs20140630d (2015).","journal-title":"Acta Cardiol. Sin"},{"key":"60840_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4070\/kcj.2012.42.2.100","volume":"42","author":"KY Choi","year":"2012","unstructured":"Choi, K. Y. et al. Higher plasma thrombospondin-1 levels in patients with coronary artery disease and diabetes mellitus. Korean Circ. J. 42, 100\u2013106. https:\/\/doi.org\/10.4070\/kcj.2012.42.2.100 (2012).","journal-title":"Korean Circ. J."},{"key":"60840_CR34","first-page":"5684","volume":"56","author":"SC Hsu","year":"1996","unstructured":"Hsu, S. C. et al. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res. 56, 5684\u20135691 (1996).","journal-title":"Cancer Res."},{"key":"60840_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000025733","volume":"37","author":"JE Nor","year":"2000","unstructured":"Nor, J. E. et al. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J. Vasc. Res. 37, 209\u2013218. https:\/\/doi.org\/10.1159\/000025733 (2000).","journal-title":"J. Vasc Res."},{"key":"60840_CR36","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1161\/ATVBAHA.120.314962","volume":"41","author":"R Ganguly","year":"2021","unstructured":"Ganguly, R. et al. TSP-1 (Thrombospondin-1) deficiency protects ApoE(-\/-) mice against leptin-induced atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 41, e112\u2013e127. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314962 (2021).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"60840_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26030987","author":"Y Chang","year":"2025","unstructured":"Chang, Y., Liu, Y., Zou, Y. & Ye, R. D. Recent advances in studies of serum amyloid A: Implications in inflammation, immunity and tumor metastasis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms26030987 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"60840_CR38","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2119\/molmed.2011.00186","volume":"17","author":"Z Dong","year":"2011","unstructured":"Dong, Z. et al. Serum amyloid A directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Mol. Med. 17, 1357\u20131364. https:\/\/doi.org\/10.2119\/molmed.2011.00186 (2011).","journal-title":"Mol. Med."},{"key":"60840_CR39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1194\/jlr.M054015","volume":"56","author":"JC Thompson","year":"2015","unstructured":"Thompson, J. C. et al. A brief elevation of serum amyloid A is sufficient to increase atherosclerosis. J. Lipid Res. 56, 286\u2013293. https:\/\/doi.org\/10.1194\/jlr.M054015 (2015).","journal-title":"J. Lipid Res."},{"key":"60840_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clinbiochem.2020.08.005","volume":"85","author":"C Chang","year":"2020","unstructured":"Chang, C., Pan, Y., Du, H., Wang, X. & Li, X. Serum amyloid A1 can be a novel biomarker for evaluating the presence and severity of acute coronary syndrome. Clin. Biochem. 85, 27\u201332. https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.08.005 (2020).","journal-title":"Clin. Biochem."},{"key":"60840_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/tan.12516","volume":"85","author":"X Xie","year":"2015","unstructured":"Xie, X. et al. Genetic polymorphisms of serum amyloid A1 and coronary artery disease risk. Tissue Antigens. 85, 168\u2013176. https:\/\/doi.org\/10.1111\/tan.12516 (2015).","journal-title":"Tissue Antigens"},{"key":"60840_CR42","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.mam.2020.100851","volume":"73","author":"A di Masi","year":"2020","unstructured":"di Masi, A. et al. Haptoglobin: From hemoglobin scavenging to human health. Mol. Aspects Med. 73, 100851. https:\/\/doi.org\/10.1016\/j.mam.2020.100851 (2020).","journal-title":"Mol. Aspects Med."},{"key":"60840_CR43","doi-asserted-by":"publisher","first-page":"e1450","DOI":"10.1002\/mgg3.1450","volume":"8","author":"X Chang","year":"2020","unstructured":"Chang, X. et al. Interaction between a haptoglobin genetic variant and coronary artery disease (CAD) risk factors on CAD severity in Singaporean Chinese population. Mol. Genet. Genomic Med. 8, e1450. https:\/\/doi.org\/10.1002\/mgg3.1450 (2020).","journal-title":"Mol. Genet. Genomic Med."},{"key":"60840_CR44","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/s0002-9149(02)02189-6","volume":"89","author":"A Roguin","year":"2002","unstructured":"Roguin, A. et al. Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation. Am. J. Cardiol. 89, 806\u2013810. https:\/\/doi.org\/10.1016\/s0002-9149(02)02189-6 (2002).","journal-title":"Am. J. Cardiol."},{"key":"60840_CR45","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1016\/j.hlc.2018.10.017","volume":"28","author":"YD Barac","year":"2019","unstructured":"Barac, Y. D. et al. Haptoglobin genotype as a prognostic factor for adverse events in coronary artery bypass surgery in diabetic patients. Heart Lung Circ. 28, e104\u2013e105. https:\/\/doi.org\/10.1016\/j.hlc.2018.10.017 (2019).","journal-title":"Heart Lung Circ."},{"key":"60840_CR46","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1159\/000447920","volume":"39","author":"Y Ji","year":"2016","unstructured":"Ji, Y. et al. Inhibition of cartilage acidic protein 1 reduces ultraviolet B irradiation induced-apoptosis through P38 mitogen-activated protein kinase and jun amino-terminal kinase pathways. Cell. Physiol. Biochem. 39, 2275\u20132286. https:\/\/doi.org\/10.1159\/000447920 (2016).","journal-title":"Cell. Physiol. Biochem."},{"key":"60840_CR47","doi-asserted-by":"publisher","first-page":"686555","DOI":"10.3389\/fneur.2021.686555","volume":"12","author":"T Kuwashiro","year":"2021","unstructured":"Kuwashiro, T. et al. Oxidized albumin and cartilage acidic protein-1 as blood biomarkers to predict ischemic stroke outcomes. Front. Neurol. 12, 686555. https:\/\/doi.org\/10.3389\/fneur.2021.686555 (2021).","journal-title":"Front. Neurol."},{"key":"60840_CR48","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1016\/j.ymthe.2024.06.027","volume":"32","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. LRG1 loss effectively restrains glomerular TGF-\u03b2 signaling to attenuate diabetic kidney disease. Mol. Ther. 32, 3177\u20133193. https:\/\/doi.org\/10.1016\/j.ymthe.2024.06.027 (2024).","journal-title":"Mol. Ther."},{"key":"60840_CR49","doi-asserted-by":"publisher","first-page":"706143","DOI":"10.3389\/fcell.2021.706143","volume":"9","author":"KT Pang","year":"2021","unstructured":"Pang, K. T. et al. Leucine-rich alpha-2-glycoprotein 1 suppresses endothelial cell activation through ADAM10-mediated shedding of TNF-alpha receptor. Front. Cell. Dev. Biol. 9, 706143. https:\/\/doi.org\/10.3389\/fcell.2021.706143 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"60840_CR50","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1210\/jc.2014-3855","volume":"100","author":"SL Pek","year":"2015","unstructured":"Pek, S. L. et al. Elevation of a novel angiogenic factor, leucine-rich-alpha2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 100, 1586\u20131593. https:\/\/doi.org\/10.1210\/jc.2014-3855 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60840_CR51","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jacl.2017.03.014","volume":"11","author":"S Bos","year":"2017","unstructured":"Bos, S. et al. Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia. J. Clin. Lipidol. 11, 682\u2013693. https:\/\/doi.org\/10.1016\/j.jacl.2017.03.014 (2017).","journal-title":"J. Clin. Lipidol."},{"key":"60840_CR52","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1038\/s41598-020-62989-7","volume":"10","author":"FJ Yang","year":"2020","unstructured":"Yang, F. J. et al. Plasma leucine-rich alpha-2-glycoprotein 1 predicts cardiovascular disease risk in end-stage renal disease. Sci. Rep. 10, 5988. https:\/\/doi.org\/10.1038\/s41598-020-62989-7 (2020).","journal-title":"Sci. Rep."},{"key":"60840_CR53","first-page":"575","volume":"53","author":"H Kitamura","year":"1984","unstructured":"Kitamura, H., Matsumoto, M. & Nagaki, K. C3-independent immune haemolysis: Haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3. Immunology 53, 575\u2013582 (1984).","journal-title":"Immunology"},{"key":"60840_CR54","doi-asserted-by":"publisher","first-page":"208","DOI":"10.2478\/jomb-2019-0022","volume":"39","author":"EM Stakhneva","year":"2020","unstructured":"Stakhneva, E. M. et al. Changes in the proteomic profile of blood serum in coronary atherosclerosis. J. Med. Biochem. 39, 208\u2013214. https:\/\/doi.org\/10.2478\/jomb-2019-0022 (2020).","journal-title":"J. Med. Biochem."},{"key":"60840_CR55","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","volume":"383","author":"SS Mahmood","year":"2014","unstructured":"Mahmood, S. S., Levy, D., Vasan, R. S. & Wang, T. J. The Framingham Heart Study and the epidemiology of cardiovascular disease: A historical perspective. Lancet 383, 999\u20131008. https:\/\/doi.org\/10.1016\/S0140-6736(13)61752-3 (2014).","journal-title":"Lancet"},{"key":"60840_CR56","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.thromres.2014.05.025","volume":"134","author":"A Schaffer","year":"2014","unstructured":"Schaffer, A. et al. Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study. Thromb. Res. 134, 288\u2013293. https:\/\/doi.org\/10.1016\/j.thromres.2014.05.025 (2014).","journal-title":"Thromb. Res."},{"key":"60840_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cca.2013.12.001","volume":"429","author":"O Perez-Mendez","year":"2014","unstructured":"Perez-Mendez, O., Pacheco, H. G., Martinez-Sanchez, C. & Franco, M. HDL-cholesterol in coronary artery disease risk: Function or structure? Clin. Chim. Acta. 429, 111\u2013122. https:\/\/doi.org\/10.1016\/j.cca.2013.12.001 (2014).","journal-title":"Clin. Chim. Acta"},{"key":"60840_CR58","first-page":"4399","volume":"8","author":"J Shen","year":"2015","unstructured":"Shen, J. et al. Correlation of serum alanine aminotransferase and aspartate aminotransferase with coronary heart disease. Int. J. Clin. Exp. Med. 8, 4399\u20134404 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"60840_CR59","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","volume":"388","author":"E Vidal-Petiot","year":"2016","unstructured":"Vidal-Petiot, E. et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: An international cohort study. Lancet 388, 2142\u20132152. https:\/\/doi.org\/10.1016\/S0140-6736(16)31326-5 (2016).","journal-title":"Lancet"},{"key":"60840_CR60","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1001\/jama.2016.16951","volume":"316","author":"SJ Nicholls","year":"2016","unstructured":"Nicholls, S. J. et al. Effect of evolocumab on progression of coronary disease in statin-treated patients: The GLAGOV randomized clinical trial. JAMA 316, 2373\u20132384. https:\/\/doi.org\/10.1001\/jama.2016.16951 (2016).","journal-title":"JAMA"},{"key":"60840_CR61","doi-asserted-by":"publisher","first-page":"e233030","DOI":"10.1148\/radiol.233030","volume":"314","author":"T Pezel","year":"2025","unstructured":"Pezel, T. et al. A Machine learning model using cardiac CT and MRI data predicts cardiovascular events in obstructive coronary artery disease. Radiology 314, e233030. https:\/\/doi.org\/10.1148\/radiol.233030 (2025).","journal-title":"Radiology"},{"key":"60840_CR62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jcct.2025.01.007","volume":"19","author":"J Lee","year":"2025","unstructured":"Lee, J. et al. Prediction of obstructive coronary artery disease using coronary calcification and epicardial adipose tissue assessments from CT calcium scoring scans. J. Cardiovasc. Comput. Tomogr. 19, 224\u2013231. https:\/\/doi.org\/10.1016\/j.jcct.2025.01.007 (2025).","journal-title":"J. Cardiovasc. Comput. Tomogr"},{"key":"60840_CR63","doi-asserted-by":"publisher","first-page":"161","DOI":"10.14503\/THIJ-17-6329","volume":"46","author":"S Yang","year":"2019","unstructured":"Yang, S., Bhatia, N., Xu, M. & McPherson, J. A. Incidence and predictors of obstructive coronary artery disease and the role of cardiac troponin assays in patients with unstable Angina. Tex. Heart Inst. J. 46, 161\u2013166. https:\/\/doi.org\/10.14503\/THIJ-17-6329 (2019).","journal-title":"Tex. Heart Inst. J."},{"key":"60840_CR64","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1056\/NEJMoa0907272","volume":"362","author":"MR Patel","year":"2010","unstructured":"Patel, M. R. et al. Low diagnostic yield of elective coronary angiography. N. Engl. J. Med. 362, 886\u2013895. https:\/\/doi.org\/10.1056\/NEJMoa0907272 (2010).","journal-title":"N Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60840-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60840-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60840-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:02:14Z","timestamp":1790942534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60840-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60840"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60840-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the First Affiliated Hospital, College of Medicine, Zhejiang University (2020; IIT No. 279). All participants provided written informed consent prior to enrollment. This study was registered in the Chinese Clinical Trial Registry (ChiCTR2100048470) on July 9, 2021.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30630"}}